Sponsor content
60 result(s) found, displaying 1 to 10
-
Jul-2026Prescription medicine evaluationActive ingredient: nirogacestat hydrobromide.
-
Jun-2026Prescription medicine evaluationActive ingredient: mirdametinib.
-
Designation or determinationPriority review
-
Designation or determinationOrphan drug
-
Designation or determinationOrphan drug
-
Cancellation by sponsorRequested by Merck Healthcare Pty Ltd
-
Cancellation by sponsorRequested by Merck Healthcare Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CLADRITAB cladribine 10mg tablet blister pack.
-
-
Prescription medicine registrationActive ingredients: Somatropin.